Company intelligence / Profile preview
PerImmune
- Ownership
- Private
- Development stage
- Other
Overview
PerImmune was a private U.S. biopharmaceutical company based in Rockville, Maryland that focused on immunotherapy, cancer vaccines, human monoclonal antibodies, and diagnostic products. Historical reports indicate the company developed products for cancer and infectious disease applications, including a KLH-based bladder cancer immunotherapy program and a physician office-based bladder cancer recurrence test. PerImmune originated from Organon Teknika through a 1996 management buyout and later merged with Intracel in 1998. The company appears to be inactive today as an independent operating business, but it left behind patents and product-development work in oncology immunotherapy and diagnostics.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- Monoclonal antibodyVaccineBiologicProtein
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on PerImmune.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PerImmune.